Douglas J. Manion
CIK 1875875 · Pres and CEO · last filed 2024-01-03
Douglas J. Manion is a Pres and CEO who has filed 9 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for ACRS, was dated Jan 3, 2024. Across all open-market trades the lifetime net is +$99.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $180.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$180.6K
2
9
$99.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Pres and CEO | 41,813 | $4.32 | $180.6K | $99.8K | 6 | 2024-01-03 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | EVP Research & Development | 0 | $99.99 | $0 | $0 | 3 | 2022-03-11 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-03 | ACRS | Mixed | +17,875 | -$9.6K | EDGAR |
| 2023-08-03 | ACRS | Mixed | +11,138 | -$43.5K | EDGAR |
| 2023-03-17 | ACRS | Buy (P) | +6,300 | $49.5K | EDGAR |
| 2023-03-09 | ACRS | Buy (P) | +6,500 | $50.3K | EDGAR |
| 2023-02-03 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2022-08-02 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2022-03-11 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | −36,462 | $0 | EDGAR |
| 2022-01-05 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | +21,462 | $0 | EDGAR |
| 2021-08-17 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | +15,000 | $0 | EDGAR |